At BICO, we’re helping create the future of health through the power of bio convergence.
Five years ago, we founded CELLINK with a vision to facilitate access to 3D bioprinting in the drug discovery industry. Bioprinting is today a key technology in the healthcare industry that helps speed up discoveries of new drugs, but also works as an accelerator in the work toward completely phasing out animal testing. The 3D bioprinting technology enables the printing of human tissue, which in turn make way for researchers to work with much more physiologically relevant tissue when testing new drugs. The technology is also extensively useful in the cosmetics industry, where products can be tested on 3D-printed human tissue rather than on animals.
The business has over the last five years expanded rapidly and is now the world’s leading Bio Convergence company with their own devices currently being used in more than 2,000 labs in 65 countries.
This year, we reorganized the company and introduced BICO, a new parent company to oversee our 12 subsidiaries which all possesses unique expertise in industries beyond just 3D bioprinting.
By combining such wide-ranged technologies like engineering, biology, computer science and robotics we can further drive innovation in the healthcare industry. The idea is called Bio Convergence which transforms into BICO – a brand representing the full width the of the business’s capacity today.
What is your inspiration:
One of our major inspirations is to help put an end to animal testing. We continue to work with the research in Bio Convergence and the uninterrupted development of current bioprinters. Thus, we continuously provide companies in the pharmaceutical and cosmetic industries with alternative technology that did not exist previously. Furthermore, we aspire to make use of our technology in the fight against some of today’s incurable diseases by developing implants and tissue replacements for clinical use.
Where do you see yourself in 5 years?
With 12 group companies that span almost every vertical of life science, we hope that the BICO brand will help the world understand our vision of bio convergence, and that we will use it to advance human health. This includes helping eliminate animal testing as more and more governments ban the practice, including the EU this year.
Considering that only five years ago, we had seven employees working out of a small lab, we have tremendous hopes for where we will be in five years. One major goal is to be recognized as one of the leading and most innovative life science companies in the worlds.
How do people get involved/buy into your vision?
We want anyone and everyone to help us usher in the bio convergence revolution. We have dozens of jobs open across disciplines including research, manufacturing, marketing, and more. If you’re a healthcare company or academic research institution, please visit our website to learn more about our products and how we can help you with your important work. For everyone else, please follow us on LinkedIn and Twitter to keep up with the latest.